{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T23:29:24Z","timestamp":1775604564142,"version":"3.50.1"},"reference-count":17,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T00:00:00Z","timestamp":1738281600000},"content-version":"vor","delay-in-days":152,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Stomatology, Oral and Maxillofacial Surgery"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.jormas.2024.101985","type":"journal-article","created":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T18:35:52Z","timestamp":1722018952000},"page":"101985","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"S1","title":["Guselkumab: A new etiological factor of medication related osteonecrosis of the jaw (MRONJ)? A case report"],"prefix":"10.1016","volume":"125","author":[{"given":"Monica","family":"Marotta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0782-9933","authenticated-orcid":false,"given":"Paolo","family":"Boffano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Errico","family":"Prota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Ferrillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Leone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vittorio","family":"Fusco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Migliario","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jormas.2024.101985_bib0001","doi-asserted-by":"crossref","DOI":"10.1111\/odi.14887","article-title":"Italian position paper (SIPMO-SICMF) on medication related osteonecrosis of jaw (MRONJ)","author":"Bedogni","year":"2024","journal-title":"Oral Dis."},{"issue":"5","key":"10.1016\/j.jormas.2024.101985_bib0002","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.joms.2022.02.008","article-title":"American association of oral and maxillofacial surgeons' position paper on medication-related osteonecrosis of the jaws-2022 update","volume":"80","author":"Ruggiero","year":"2022","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.jormas.2024.101985_bib0003","article-title":"Osimertinib: another medication related to osteonecrosis of the jaws? A case report and literature review","volume":"13","author":"Wang","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jormas.2024.101985_bib0004","article-title":"Tocilizumab: another medication related to osteonecrosis of the jaws? A case report and literature review","volume":"10","author":"Sakkas","year":"2021","journal-title":"GMS Interdiscip Plast Reconstr Surg DGPW"},{"issue":"1","key":"10.1016\/j.jormas.2024.101985_bib0005","doi-asserted-by":"crossref","first-page":"132","DOI":"10.29252\/wjps.10.1.132","article-title":"Medication-related osteonecrosis of the jaw (MRONJ) due to simvastatin: an unusual case report","volume":"10","author":"Samieirad","year":"2021","journal-title":"World J Plast Surg"},{"issue":"3","key":"10.1016\/j.jormas.2024.101985_bib0006","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s10006-020-00931-x","article-title":"Bosutinib-induced osteonecrosis of the jaw in a patient with chronic myeloid leukemia: a case report","volume":"25","author":"Myoken","year":"2021","journal-title":"Oral Maxillofac Surg"},{"issue":"3","key":"10.1016\/j.jormas.2024.101985_bib0007","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jormas.2019.06.009","article-title":"Rituximab as a trigger factor of medication-related osteonecrosis of the jaw. A case report","volume":"121","author":"Javelot","year":"2020","journal-title":"J Stomatol Oral Maxillofac Surg"},{"key":"10.1016\/j.jormas.2024.101985_bib0008","article-title":"Medication-related osteonecrosis of the jaw: a case report of an unusual side effect of adalimumab","volume":"2023","author":"Sisalli","year":"2023","journal-title":"Case Rep Dent"},{"issue":"10","key":"10.1016\/j.jormas.2024.101985_bib0009","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.bjoms.2023.08.241","article-title":"Pembrolizumab related osteonecrosis of the jaw","volume":"61","author":"Patel","year":"2023","journal-title":"Br J Oral Maxillofac Surg"},{"issue":"5","key":"10.1016\/j.jormas.2024.101985_bib0010","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s40264-013-0058-2","article-title":"Strategies to improve adverse drug reaction reporting: a critical and systematic review","volume":"36","author":"Gonzalez-Gonzalez","year":"2013","journal-title":"Drug Saf"},{"issue":"9237","key":"10.1016\/j.jormas.2024.101985_bib0011","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0140-6736(00)02799-9","article-title":"Adverse drug reactions: definitions, diagnosis, and management","volume":"356","author":"Edwards","year":"2000","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.jormas.2024.101985_bib0012","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1080\/14712598.2018.1445223","article-title":"Guselkumab for the treatment of psoriasis","volume":"18","author":"Megna","year":"2018","journal-title":"Expert Opin Biol Ther"},{"issue":"1","key":"10.1016\/j.jormas.2024.101985_bib0013","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/1744666X.2020.1857733","article-title":"Guselkumab: the first selective IL-23 inhibitor for active psoriatic arthritis in adults","volume":"17","author":"Boehncke","year":"2021","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.jormas.2024.101985_bib0014","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1007\/s00228-016-2110-5","article-title":"First-in-human study to assess guselkumab (anti-IL-23 mAb) pharmacokinetics\/safety in healthy subjects and patients with moderateto-severe psoriasis","volume":"72","author":"Zhuang","year":"2016","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jormas.2024.101985_bib0015","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1111\/j.0022-202X.2004.23448.x","article-title":"A phase I study evaluating the safety, pharmacokinetics, and clinical response of a human IL-12 p40 antibody in subjects with plaque psoriasis","volume":"123","author":"Kauffman","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jormas.2024.101985_bib0016","article-title":"Efficacy and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: results of the randomized, double-blind, phase III NAVIGATE trial","author":"Langley","year":"2017","journal-title":"Br J Dermatol"},{"issue":"10230","key":"10.1016\/j.jormas.2024.101985_bib0017","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/S0140-6736(20)30263-4","article-title":"Guselkumab in biologic-naive patients with active psoriatic arthritis (DISCOVER-2): a double-blind, randomised, placebo-controlled phase 3 trial","volume":"395","author":"Mease","year":"2020","journal-title":"Lancet"}],"container-title":["Journal of Stomatology, Oral and Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468785524002313?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468785524002313?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T15:34:04Z","timestamp":1738510444000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468785524002313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S2468785524002313"],"URL":"https:\/\/doi.org\/10.1016\/j.jormas.2024.101985","relation":{},"ISSN":["2468-7855"],"issn-type":[{"value":"2468-7855","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Guselkumab: A new etiological factor of medication related osteonecrosis of the jaw (MRONJ)? A case report","name":"articletitle","label":"Article Title"},{"value":"Journal of Stomatology, Oral and Maxillofacial Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jormas.2024.101985","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"101985"}}